Gangadhar, T. C. & Vonderheide, R. H. Mitigating the toxic effects of anticancer immunotherapy. Nat. Rev. Clin. Oncol. 11, 91–99 (2014).

Article  CAS  PubMed  Google Scholar 

Bower, J. E. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 11, 597–609 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stone, J. B. & DeAngelis, L. M. Cancer-treatment-induced neurotoxicity — focus on newer treatments. Nat. Rev. Clin. Oncol. 13, 92–105 (2016).

Article  CAS  PubMed  Google Scholar 

Holohan, C., Van Schaeybroeck, S., Longley, D. B. & Johnston, P. G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer 13, 714–726 (2013).

Article  CAS  PubMed  Google Scholar 

Vasan, N., Baselga, J. & Hyman, D. M. A view on drug resistance in cancer. Nature 575, 299–309 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drago, J. Z., Modi, S. & Chandarlapaty, S. Unlocking the potential of antibody-drug conjugates for cancer therapy. Nat. Rev. Clin. Oncol. 18, 327–344 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Llovet, J. M., Montal, R., Sia, D. & Finn, R. S. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 15, 599–616 (2018).

Article  PubMed  Google Scholar 

Davis, M. E., Chen, Z. G. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771–782 (2008).

Article  CAS  PubMed  Google Scholar 

Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).

Article  CAS  Google Scholar 

Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751–760 (2007).

Article  CAS  PubMed  Google Scholar 

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M. & Peer, D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9, 1410 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).

Article  CAS  PubMed  Google Scholar 

Patra, J. K. et al. Nano based drug delivery systems: recent developments and future prospects. J. Nanobiotechnol. 16, 71 (2018).

Article  Google Scholar 

Barenholz, Y. Doxil® — the first FDA-approved nano-drug: lessons learned. J. Control. Rel. 160, 117–134 (2012).

Article  CAS  Google Scholar 

Yardley, D. A. nab-Paclitaxel mechanisms of action and delivery. J. Control. Rel. 170, 365–372 (2013).

Article  CAS  Google Scholar 

Lancet, J. E. et al. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J. Clin. Oncol. 36, 2684–2692 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi, J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17, 20–37 (2017).

Article  CAS  PubMed  Google Scholar 

Suk, J. S., Xu, Q. G., Kim, N., Hanes, J. & Ensign, L. M. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99, 28–51 (2016).

Article  CAS  PubMed  Google Scholar 

Abu Lila, A. S., Kiwada, H. & Ishida, T. The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage. J. Control. Rel. 172, 38–47 (2013).

Article  CAS  Google Scholar 

Torchilin, V. Tumor delivery of macromolecular drugs based on the EPR effect. Adv. Drug Deliv. Rev. 63, 131–135 (2011).

Article  CAS  PubMed  Google Scholar 

Wu, C. H., Liu, I. J., Lu, R. M. & Wu, H. C. Advancement and applications of peptide phage display technology in biomedical science. J. Biomed. Sci. 23, 8 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Little, M., Kipriyanov, S. M., Le Gall, F. & Moldenhauer, G. Of mice and men: hybridoma and recombinant antibodies. Immunol. Today 21, 364–370 (2000).

Article  CAS  PubMed  Google Scholar 

Darmostuk, M., Rimpelova, S., Gbelcova, H. & Ruml, T. Current approaches in SELEX: an update to aptamer selection technology. Biotechnol. Adv. 33, 1141–1161 (2015).

Article  CAS  PubMed  Google Scholar 

Yoo, J. W., Irvine, D. J., Discher, D. E. & Mitragotri, S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10, 521–535 (2011).

Article  CAS  PubMed  Google Scholar 

Fang, R. H., Kroll, A. V., Gao, W. & Zhang, L. Cell membrane coating nanotechnology. Adv. Mater. 30, 1706759 (2018).

Article  Google Scholar 

Fang, R. H., Jiang, Y., Fang, J. C. & Zhang, L. Cell membrane-derived nanomaterials for biomedical applications. Biomaterials 128, 69–83 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molinaro, R. et al. Biomimetic proteolipid vesicles for targeting inflamed tissues. Nat. Mater. 15, 1037–1046 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toledano Furman, N. E. et al. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. Nano Lett. 13, 3248–3255 (2013).

Article  CAS  PubMed  Google Scholar 

Jiang, Y., Chekuri, S., Fang, R. H. & Zhang, L. Engineering biological interactions on the nanoscale. Curr. Opin. Biotechnol. 58, 1–8 (2019).

Article  CAS  PubMed  Google Scholar 

Krishnan, N., Fang, R. H. & Zhang, L. Engineering of stimuli-responsive self-assembled biomimetic nanoparticles. Adv. Drug Deliv. Rev. 179, 114006 (2021).

Article  CAS  PubMed  Google Scholar 

Oldenborg, P. A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051–2054 (2000).

Article  CAS  PubMed  Google Scholar 

Hu, C.-M. J. et al. ‘Marker-of-self’ functionalization of nanoscale particles through a top-down cellular membrane coating approach. Nanoscale 5, 2664–2668 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang, R. H. et al. Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett. 14, 2181–2188 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu, C. M. et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature 526, 118–121 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou, J. et al. Physical disruption of solid tumors by immunostimulatory microrobots enhances antitumor immunity. Adv. Mater. 33, 2103505 (2021).

Article  CAS  Google Scholar 

Jiang, Y. et al. Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity. Adv. Mater. 32, 2001808 (2020).

Article  CAS  Google Scholar 

Hu, C. M. et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc. Natl Acad. Sci. USA 108, 10980–10985 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noris, M. & Remuzzi, G. Overview of complement activation and regulation. Semin. Nephrol. 33, 479–492 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fang, R. H., Hu, C. M. J. & Zhang, L. F. Nanoparticles disguised as red blood cells to evade the immune system. Expert Opin. Biol. Ther. 12, 385–389 (2012).

Article  CAS